[144] Pegasystems Inc SEC Filing

Rhea-AI Filing Summary

Pegasystems Inc. reported a proposed sale under Rule 144 of 4,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $222,040. The shares represent restricted stock units acquired on 06/01/2025 and are scheduled for sale on or about 09/08/2025. The issuer's reported shares outstanding are 171,080,665, making this planned sale immaterial in percentage terms to total outstanding shares. The filing also discloses a prior 10b5-1 sale of 2,000 shares on 09/02/2025 that generated $106,808.20 in gross proceeds. The filer affirms no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Small insider disposition of RSUs; immaterial to capitalization but notable for insider liquidity.

The filing indicates an insider plans to sell 4,000 shares acquired as restricted stock units on 06/01/2025, via Morgan Stanley, valued at $222,040. With 171.08 million shares outstanding, the position is negligible relative to market capitalization, so there is no immediate dilution or balance-sheet impact. The earlier 10b5-1 sale of 2,000 shares on 09/02/2025 for $106,808.20 shows ongoing, structured disposition activity rather than a block sale. Rating: 0 (neutral).

Compliance/Risk Analyst

TL;DR: Filing appears compliant with Rule 144 and discloses a 10b5-1 sale; no red flags in the notice itself.

The Form 144 lists acquisition as restricted stock units and shows dates for both acquisition and planned sale, plus a prior 10b5-1 execution, aligning with standard disclosure expectations. The signer represents no undisclosed material adverse information, and the broker is identified. The filing contains the customary attestation language and no explicit compliance exceptions are noted. Rating: 0 (neutral).

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4000	222040.00	171080665	09/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2025	Restricted Stock Units	Issuer			4000	06/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for RIFAT KERIM AKGONUL 225 Wyman Street Waltham MA 02451	Common	09/02/2025	2000	106808.20

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is the number of shares Pegasystems (PEGA) proposed to sell under this Form 144?

The filing shows a proposed sale of 4,000 common shares with an aggregate market value of $222,040.

When were the shares acquired and by what method?

The 4,000 shares were acquired on 06/01/2025 as restricted stock units from the issuer.

Who is the broker handling the proposed sale?

The broker listed is Morgan Stanley Smith Barney LLC, 1 New York Plaza, 8th Floor, New York, NY 10004.

Has the filer sold any Pegasystems shares recently?

Yes. A prior 10b5-1 sale of 2,000 shares occurred on 09/02/2025, generating $106,808.20 in gross proceeds.

What percentage of outstanding shares does the proposed sale represent?

The filing reports 171,080,665 shares outstanding; 4,000 shares are a de minimis percentage of that total.